165 related articles for article (PubMed ID: 3370988)
21. Annual variation in semen characteristics and plasma hormone levels in men undergoing vasectomy.
Reinberg A; Smolensky MH; Hallek M; Smith KD; Steinberger E
Fertil Steril; 1988 Feb; 49(2):309-15. PubMed ID: 3123279
[TBL] [Abstract][Full Text] [Related]
22. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
23. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
24. Testosterone and gossypol effects on human sperm motility.
Ridley AJ; Blasco L
Fertil Steril; 1981 Nov; 36(5):638-42. PubMed ID: 6273239
[TBL] [Abstract][Full Text] [Related]
25. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
[TBL] [Abstract][Full Text] [Related]
26. [A possible mechanism of gossypol-induced hypokalemia and its relation to gossypol dose].
Wang YX; Chen ZX
Shengzhi Yu Biyun; 1991 May; 11(2):34-8. PubMed ID: 12317367
[TBL] [Abstract][Full Text] [Related]
27. Vaginal contraception with gossypol: a clinical study.
Ratsula K; Haukkamaa M; Wichmann K; Luukkainen T
Contraception; 1983 Jun; 27(6):571-6. PubMed ID: 6684533
[TBL] [Abstract][Full Text] [Related]
28. Gossypol blood levels and inhibition of spermatogenesis in men taking gossypol as a contraceptive. A multicenter, international, dose-finding study.
Coutinho EM; Athayde C; Atta G; Gu ZP; Chen ZW; Sang GW; Emuveyan E; Adekunle AO; Mati J; Otubu J; Reidenberg MM; Segal SJ
Contraception; 2000 Jan; 61(1):61-7. PubMed ID: 10745071
[TBL] [Abstract][Full Text] [Related]
29. Endocrinology of male infertility.
de Kretser DM
Br Med Bull; 1979 May; 35(2):187-92. PubMed ID: 387166
[TBL] [Abstract][Full Text] [Related]
30. Follow-up of men in the recovery period immediately after the cessation of gossypol treatment.
Meng GD; Zhu JC; Chen ZW; Wong LT; Zhang GY; Hu YZ; Ding JH; Wang XH; Qian SZ; Wang C
Contraception; 1988 Feb; 37(2):119-28. PubMed ID: 3131064
[TBL] [Abstract][Full Text] [Related]
31. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
[TBL] [Abstract][Full Text] [Related]
32. An analysis of the direct effects of gossypol on human spermatozoa.
Aitken RJ; Liu J; Best FS; Richardson DW
Int J Androl; 1983 Apr; 6(2):157-67. PubMed ID: 6862672
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of changes of serum gonadotropins and steroid hormones in azoospermic men caused by gossypol and other factors].
Chang GY; Zhao XY; Gao SM; Guo ZS; Lui GZ; Cao J
Shengzhi Yu Biyun; 1983 Feb; 3(2):31-5. PubMed ID: 12339175
[TBL] [Abstract][Full Text] [Related]
34. Dynamic testing of hypothalamic-pituitary function in abnormalities of ovulation.
Jones GE; Wentz AC; Rosenwaks Z; Shoemaker J
Am J Obstet Gynecol; 1977 Dec; 129(7):760-76. PubMed ID: 343592
[TBL] [Abstract][Full Text] [Related]
35. [Combined use of steroid hormone and low dose gossypol for antifertility and its mechanism in rats].
Wang L; Ye W; Liu X; Guo Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Jun; 22(3):214-9. PubMed ID: 12903462
[TBL] [Abstract][Full Text] [Related]
36. Development of male-fertility-regulating agents.
Ray S; Verma P; Kumar A
Med Res Rev; 1991 Sep; 11(5):437-72. PubMed ID: 1943328
[TBL] [Abstract][Full Text] [Related]
37. The effects of cyclic adenosine monophosphate, forskolin, and theophylline on motility parameters in gossypol-treated human sperm.
Cowart CL; London SN; Vernon MW; Pedigo NG
Fertil Steril; 1994 May; 61(5):929-34. PubMed ID: 8174733
[TBL] [Abstract][Full Text] [Related]
38. Pregnancies associated with sperm concentrations below 10 million/ml in clinical studies of a potential male contraceptive method, monthly depot medroxyprogesterone acetate and testosterone esters.
Barfield A; Melo J; Coutinho E; Alvarez-Sanchez F; Faundes A; Brache V; Leon P; Frick J; Bartsch G; Weiske WH; Brenner P; Mishell D; Bernstein G; Ortiz A
Contraception; 1979 Aug; 20(2):121-7. PubMed ID: 487815
[TBL] [Abstract][Full Text] [Related]
39. Recovery of sperm production following the cessation of gossypol treatment: a two-centre study in China.
Meng GD; Zhu JC; Chen ZW; Wong LT; Zhang GY; Hu YZ; Ding JH; Wang XH; Qian SZ; Wang C
Int J Androl; 1988 Feb; 11(1):1-11. PubMed ID: 3356480
[TBL] [Abstract][Full Text] [Related]
40. An examination of blood steroid and gonadotropin concentrations in relation to fertility status and testicular function in men.
Pierrepoint CG; Jenkins BM; Wilson DW; Phillips MJ; Gow JG
Fertil Steril; 1982 Oct; 38(4):465-70. PubMed ID: 6811340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
